Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors

NCT05623891 is registered in ClinicalTrials.gov with Affiliated Hospital of Jiangnan University as lead sponsor.

NCT NCT05623891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05623891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors
Lead sponsor
Affiliated Hospital of Jiangnan University
Phase
Phase 1
Overall status
Unknown status
Start date
December 31, 2022
Completion date
December 31, 2023
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor, adult